Papers

8

Total Citations

87

H-Index

5

About

Dr. Akiko Serizawa is a pioneering surgeon at the forefront of robotic and minimally invasive gastrectomy for gastric cancer. Her research focuses on advancing surgical robotics, including the innovative use of the hinotori™ and Da Vinci SP systems, to improve patient outcomes. Dr. Serizawa’s major contributions include demonstrating the safety and feasibility of robotic total and distal gastrectomy, even for highly advanced gastric cancer following preoperative chemotherapy. Her work on standardizing robotic procedures has been cited over 80 times, with key papers on robotic gastrectomy using the hinotori™ system and propensity-score matched analyses of total gastrectomy each garnering 27 citations. Notably, she has shown that non-qualified surgeons can safely perform robotic distal gastrectomy, expanding access to these advanced techniques. Dr. Serizawa also addresses critical postoperative issues, such as diarrhea and intestinal complications, through standardized protocols. Her clinical leadership at a single institution, analyzing over 1,400 patients, underscores her impact. By refining robotic esophagectomy and single-port surgery, Dr. Serizawa is shaping the future of gastric cancer surgery, making it safer and more effective for patients worldwide.

Research Focus

Key Achievements

5
H-Index
8
Papers
87
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
First clinical experiences of robotic gastrectomy for gastric cancer using the hinotori™ surgical robot system
27 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Fujita Health University, Fujita Health University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago